Protection by 4-methylthiobenzoic acid against cisplatin-induced ototoxicity: Antioxidant system

Pharmacology and Toxicology

Volumn 81, Issue 4, 1997, Pages 173-179

  Rybak, Leonard P ^a   Husain, Kazim ^a   Evenson, L ^b   Morris, Craig ^a   Whitworth, Craig ^a   Somani, Satu M ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (METHYLTHIO)BENZOIC ACID; ANTIOXIDANT; BENZOIC ACID DERIVATIVE; CATALASE; CISPLATIN; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; EVOKED AUDITORY RESPONSE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; OTOTOXICITY; PRIORITY JOURNAL; RAT;

ANIMALIA; RATTUS NORVEGICUS;

EID: 0030801599     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0773.1997.tb02065.x     Document Type: Article

References (58)

1. Aebi, N.: Catalase in vitro. Meth. Enzymol. 1984, 105, 121-126.
2. Anderson, M. E., A. Naganuma & A. Meister: Protection against cisplatin toxicity by administration of glutathione ester. FASEB J. 1990, 4, 3251-3255.
3. Awasthi, Y. C., S. V. Singh, H. Ahmad, L. W. Wronski, S. K. Srivasthava & E. F. LaBelle: ATP dependent primary active transport of xenobiotic-glutathione conjugates by human erythrocyte membrane. Mol. Cell. Biochem. 1989, 91, 131-136.
4. Ban, M., D. Hettich, & N. Huguet: Nephrotoxicity mechanism of cis-platinum (II) diamine dichloride in mice. Toxicol. Lett. 1994, 71, 161-168.
5. Basinger, M. A., M. M. Jones & M. A. Holscher: L-methionine antagonism of cis-platinum-induced nephrotoxicity. Toxicol. Appl. Pharmacol. 1990, 103, 1-15, 1990.
6. Berry, J. M., C. Jacobs, B. Sikic, J. Halsey & R. F. Borch: Modification of cisplatin toxicity with diethyldithiocarbamate. J. Clin. Oncol. 1990, 8, 1585-1590.
7. Borch, R. F., J. C. Katz, P. N. Lieder & M. E. Pleasants: Effect of diethyldithiocarbamate rescue on tumor response to platinum in a rat model. Proc. Natl. Acad. Sci. 1980, 77(9), 5441-5444.
8. Boogaard, P. J., E. L. Lempers, G. J. Mudler & J. H. N. Meerman: 4-methylthiobenzoic acid reduces cisplatin nephrotoxicity in rats without compromising anti-tumor activity. Biochem. Pharmacol. 1991, 41, 1997-2003.
9. Carlberg, I. & B. Mannervik: Glutathione reductase. Meth. Enzymol. 1985, 113, 484-490.
10. Church, M. W., J. A. Kaltenbach, B. W. Blakley & D. L. Bungio: The comparative effects of sodium thiosulfate diethyldithiocarbamate, fosfomycin and WR-2721 on ameliorating cisplatin-induced ototoxicity. Hearing Res. 1995, 86, 195-203.
11. Clerici, W. J., D. L. DiMartino & M. R. Prasad: Direct effects of reactive oxygen species on cochlear outer hair cell shape in vitro. Hearing Res. 1995, 84, 30-40.
12. DeWeskin, R. S. & J. E. Riviere: Cisplatin-induced loss of kidney copper and nephrotoxicity is ameliorated by single dose of diethyldithiocarbamate but not mesna. Toxicol. Appl. Pharmacol. 1992, 112, 182-189.
13. Deleve, S. M. & N. Kaplowitz: Importance and regulation of hepatic glutathione. Sami. Liv. Dis. 1990, 10, 251-256.
14. Dobyan, D. C., J. M. Bull, F. R. Strebel, B. A. Sunderland & R. E. Bulger: Protective effects of O-beta- hydroxyethyl-rutoside on cisplatin-induced acute renal failure in the rat. Lab. Invest. 1986, 55, 557-563.
15. Fariss, M. W. & D. J. Reed: High performance liquid chromatography of thios and disulfides: dinitrophenol derivatives. Meth. Enzymol. 1987, 143, 101-109.
16. Fausti, S. A., M. A. Schechter, B. Z. Rapport, R. H. Frey & R. E. Mass: Cisplatin ototoxicity: selected case reports. Cancer 1984, 53, 224-231.
17. Fausti, S., H. James, H. Schaffer, D. Olson, R. Frey & G. Bagby: High frequency monitoring for early detection of cisplatin ototoxicity. Arch. Otolaryngol. Head Neck Surg. 1993, 119, 661-665.
18. Flohe, L. & W. Gunzler: Assays of glutathione peroxidase. Meth. Enzymol. 1984, 105, 114-121.
19. Fontanelli, R., G. Spatti, F. Raspagliesi, F. Zunino & F. Di Re: A preoperative single course of high dose cisplatin and bleomycin with glutathione protection in bulky stage IB/11 carcinoma of the cervix. Ann. Oncol. 1992, 3, 117-121.
20. Gandara, D. R., E. A. Perez, V. Weibe & M. W. DeGregorio: Cisplatin chemoprotection and rescue: Pharmacologic modulation of toxicity. Semin. Oncol. 1991, 18, 49-55.
21. Gandara, D. R., V. J. Wiebe, E. A. Perez, R. W. Makuch & M. W. DeGregorio: Cisplatin rescue therapy: Experience with sodium thiosulfate, WR2721, and diethyldithiocarbamate. Crit. Rev. Oncol. Hematol. 1990, 10, 353-365.
22. Hamers, F. P. T., J. H. Brakkee, E. Cavalletti, M. Tedeschi, L. Marmonti, G. Pezzoni, J. P. Neijt & W. H. Gispen: Reduced glutathione protects against cisplatin-induced neurotoxicity in rats. Cancer Res. 1993, 53, 544-549, 1993.
23. Hannemann, J. & K. Baumann: Cisplatin-induced lipid peroxidation and decrease of gluconeogenesis in rat kidney cortex: different effects of antioxidants and radical scavengers. Toxicol. 1988, 51, 119-131.
24. Howell, S. B., C. E. Pfeifle, W. E. Wung & R. A. Olshen: Intraperitoneal cisdiamminedichloroplatinum with systemic thiosulfate protection. Cancer Res. 1983, 43(3), 1426-1431.
25. Husain, K., C. Morris, C. Whitworth, G. L. Trammel & L. P. Rybak: 4-Methylthiobenzoic acid protection against cisplatin nephrotoxicity: antioxidant system. Fundam. Appl. Toxicol. 1996, 32, 278-284.
26. Ikeda, K., H. Sunose & T. Takasaka: Effects of free radicals on the intracellular calcium concentration in the isolated outer hair cell of the guinea pig cochlea. Acta otolaryngol. (Stockholm) 1993, 113, 137-141.
27. Ishikawa, T.: The ATP-dependant glutathione S-conjugate export pump. Trends Biochem. Sci. 1992, 17, 463-468.
28. Jones, M. M., M. A. Basinger & M. A. Holscher: Thioether suppression of cisplatin nephrotoxicity in the rat. Anticancer Res. 1991, 11, 449-454.
29. Jones, M. M., M. A. Basinger & M. A. Holscher: Control of the nephrotoxicity of cisplatin by clinically used sulphur-containing compounds. Fund. Appl. Toxicol. 1992, 18, 181-188.
30. Lautermann, J., B. Song, J. McLaren & J. Schacht: Diet is a risk factor in cisplatin ototoxicity. Heuring Res. 1995a, 88, 47-53.
31. Lautermann, J., J. McLaren & J. Schacht: Glutathione protection against gentamicin ototoxicity depends on nutritional status. Hearing Res. 1995b, 86, 15-24.
32. Leeuwenkamp, O. R., W. J. Van Der Vijgh, J. P. Neijt & H. M. Pinedo: Reaction kinetics of cisplatin and its monoaquated species with the (potential) renal protecting agents (di) mesna and thiosulfate. Estimation of the effect of protecting agents on the plasma and periotoneal AUCs of CDDP. Cancer Chemother. Pharmacol. 1990, 27(2), 111-114.
33. Locatelli, M. C., A. D'Antona, M. Vinci, M. Clerici, R. Cablanca, R, Carrinne, C. Pasquinuool & C. Lupurini: Cisplatin + cyclophosphamide + reduced glutathione in advanced epithelial ovarian carcinoma. Eur. J. Cancer 1991, 27, 134.
34. Markman, M., R. D'Acquito, N. Iannoti, H. Kois, T. Hakes, D. Bajorin, G. Bosl, B. Reichman, E. Casper & G. Magill: Phase I trial at high dose intravenous cisplatin with simultaneous intravenous sodium thiosulphate. J. Can. Res. Clin. Oncol. 1991, 117, 151-155.
35. McGuiness, J. E., P. Proctor & H. Demopoulos: Amelioration of cisplatinum nephrotoxicity by orgotein (Superoxide dismutase). Physiol. Chem. Phys. 1978, 10, 269-277.
36. Misra, H. P. & I. Fridovich: The role of superoxide anion in the autooxidation of the epinephrine and a sample assay for superoxide dismutase. J. Biol. Chem. 1972, 247, 3170-3175.
37. Mistry, P., Y. Merazza, D. J. Spargo, P. A. Riley & D. C. H. McBrien: The effects of cisplatin on the concentration of protein thiols and glutathione in the rat kidney. Cancer Chemother. Pharmacol. 1991, 28, 277-282.
38. Naganuma, A., M. E. Anderson & A. Meister: Cellular glutathione is a determinant of sensitivity to mercuric chloride toxicity: prevention of toxicity by giving glutathione monoester. Biochem. Pharmacol, 1990, 40, 693-697.
39. Ohkawa, H., N. Ohishi & K. Yagi: Assay for lipid peroxides in animals and tissue by thiobarbituric acid reaction. Anal. Biochem. 1979, 95, 351-358.
40. Otto, N. C., R. D. Brown, L. Gage-White, S. Kupetz, M. Anniko, J. E. Penny & C. M. Henley: Effects of cisplatin and thiosulphate upon auditory brain stem responses of guinea pig. Hear. Res. 1988, 35, 79-85.
41. Pigeolet, E., P. Corbisier, A. Houbion, D. Lambert, C. Michiels, M. Raes, M. D. Zachary & J. Ramacle: Glutathione peroxidase, superoxide dismutase and catalase inactivation by peroxides and oxygen derived free radicals. Mech. Ag. Der. 1990, 51, 283-297.
42. Powis, G. D. & M. P. Hacker: The toxicity of anticancer drugs. Pergamon Press, New York, 1991, p. 82-105.
43. Qazi, R., A. Y. Chang, R. F. Borch, T. Montine, P. Dedon, J. Loughner & J.M. Bennett: Phase I clinical and pharmacokinetic study of diethyldithiocarbamate as a chemoprotector from toxic effects of cisplatin. J. Natl. Cancer Inst. 1988, 80(18), 1486-1488.
44. Ravi, R., S. M. Somani & L. P. Rybak: Mechanism of cisplatin ototoxicity: Antioxidant system. Pharmacology & Toxicology 1995, 76, 386-394.
45. Read, S. M. & D. H. Northcole: Minimization of variation in the response to different protein of the coomassie blue G dye-binding assay for protein. Anal. Biochem. 1981, 116, 53-64, 1981.
46. Rybak, L. P., R. Ravi & S. M. Somani: Mechanism of protection by diethyldithiocarbamate against cisplatin ototoxicity: Antioxidant system. Fund. Appl. Toxicol. 1995, 26, 293-300.
47. Rybak, L. P.: Cisplatinum associated hearing loss. J. Laryngol. Otol. 1981, 95, 745-757.
48. Singhal, R. K., M. E. Anderson & A. Meister: Glutathione, a first line of defense against cadmium toxicity. FASEB J. 1987, 1, 220-3.
49. Smith, V. C. & J. R. Mitchell: Pharmacological aspects of glutathione in drug metabolism. Glutathione: Chemical, biochemical, and medical aspects. Eds.: D. Dolphin, O. Avramovibc, and R. Poulson. Wiley Press, New York, 1989.
50. Somani, S. M., R. Ravi & L. P. Rybak: Diethyldithiocarbamate protection against cisplatin nephrotoxicity: Antioxidant system. Drug Chem. Toxicol. 1995, 18, 151-170.
51. Song, B. B. & J. Schacht: Variable efficacy of radical scavengers and iron chelators to attenuate gentamicin ototoxicity in guinea pig in vivo. Hearing Res. 1996, 94, 87-93.
52. Van den Goorbergh, J. A. M., H. de Wit, R. B. Tijdens, G. J. Mulder & J. H. N. Meerman: Prevention by thioethers of the hepatotoxicity and covalent binding to macromolecules of n-hydroxy-2-acetyl-aminofluorene and its sulfate ester in rat liver in vivo and in vitro. Carcinogenesis, 1987, 8, 275-279.
53. Walker, E. M. J., M. A. Fazekas-May, K.W. Heard, S. Yee, D. Montague, D. & M. M. Jones: Prevention of cisplatin-induced toxicity by selected thiocarbamates. Ann. Clin. Lab. Sci. 1994, 24, 121-133.
54. Younes, M. & C. P. Siegers: Mechanistic aspects of enhanced lipid peroxidation following glutathione depletion in vivo. Chem. Biol. Interact. 1981, 34, 257-266.
55. Yuhas, J. M. & F. Culo: Selective inhibition of the nephrotoxicity of cis-dichlorodiammineplatinum (II) by WR2721 without altering its antitumor properties. Cancer Treat. Rep. 1980, 64, 57-64.
56. Zhang, J. G., L. F. Zhong, M. Zhang & X. Xia-Y: Protection effects of procaine on oxidative stress and toxicities of renal cortical slices from rats caused by cisplatin in in vitro. Arch. Toxicol. 1992, 66(5), 354-358.
57. Zunino, F., G. Pratesi, A. Micheloni, E. Cavalletti, F. Sala & O. Tofanetti: Protective effect of reduced glutathione against cisplatin-induced renal and systemic toxicity and its influence on the therapeutic activity of the antitumor drug. Chem. Biol. Interact. 1989, 70, 89-101.
58. Zunino, F., O. Tofanetti, A. Besati, E. Cavalletti & G. Savi: Protective effect of reduced glutathione against cis-dichlorodiammine platinum (II)-induced nephrotoxicity and lethal toxicity. Tumori 1983, 69, 105-111.